Catalyst Wire Dossier Catalyst Wire Dossier

Hyaluronic Acid 0.2%

hyaluronic acid
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hyaluronic Acid 0.2%, covering 2020-12-19 to 2020-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Hyaluronic Acid 0.2% Application Enhanced Chronic Periodontitis Treatment in Non-surgical Phase [Phase 4]

See pricing